News

Science, scrutiny and staying power: Dr. Sophia Ran’s two decades of cancer research

The rules of scientific research have changed dramatically over the past two decades. Grants are more competitive. Expectations for rigor, repeatability and transparency are higher. And researchers must now juggle cutting-edge methods with rising regulatory demands while pushing for breakthroughs. Quietly yet influentially, Dr. Sophia Ran has met those challenges head-on. Since arriving at SIU School of Medicine in 2003, Ran, has maintained continuous funding from the National Institutes of Health (NIH), the Department of Defense and other agencies, a rare feat even among seasoned
Trial
Psychiatry

ITI-007-321: An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone in the Treatment of Pediatric Patients with Schizophrenia, Bipolar Disorder, or Autism Spectrum Disorder

Active recruiting
The primary objective is to evaluate the efficacy of lumateperone administered orally for at least 26 weeks in pediatric patients with schizophrenia (aged 13 to 17 years) or pediatric patients with bipolar disorder (aged 10 to 17 years), or pediatric patients with irritability associated with autism spectrum disorder (ASD) (aged 5 to 17 years).
News

Diagnostic Radiology celebrates 2025 graduates

SIU Radiology held its annual graduation ceremony on June 6.
News

Diagnostic Radiology celebrates 2025 graduates

SIU Radiology held its annual graduation ceremony on June 6.
News

SIU Radiology welcomes 2025 incoming residents

Congratulations to our newest members of the SIU Radiology team.
News

SIU Radiology welcomes 2025 incoming residents

Congratulations to our newest members of the SIU Radiology team.
Subscribe to